What does Silo Pharma, Inc. do?

Silo Pharma, Inc. operates as a developmental stage biopharmaceutical company. The company is developing therapeutics that address underserved conditions, including post-traumatic stress disorder (PTSD), stress-induced anxiety disorders, fibromyalgia, and central nervous system (CNS) diseases. It focuses on…

What is Silo Pharma, Inc.'s P/E and P/B ratio?

Silo Pharma, Inc. has a P/E ratio of -0.3 and a P/B ratio of 0.50.

What is Silo Pharma, Inc.'s debt-to-equity ratio?

Silo Pharma, Inc. has a debt-to-equity ratio of 0.00.

How much does Silo Pharma, Inc. owe compared with what it owns?

Silo Pharma, Inc. owes $0.18 for every $1 it owns (balance sheet Jun 2026), which is low.

Does Silo Pharma, Inc. have any regulatory orders, red flags (PosiRed) or yellow flags (PosiYellow)?

Yes. Silo Pharma, Inc. has 1 active red flag (PosiRed) on record: Stock exchange listing-rule deficiency notice (8-K Item 3.01) (dated 29 Dec 2025). It has no yellow flags.

Where can I read the latest news about Silo Pharma, Inc.?

Recent headlines about Silo Pharma, Inc. from the last 30 days, with links to the original articles, are on its News page on PositoAI.

Does Silo Pharma, Inc. have a PositoAI PosiShot or QR code?

Yes. A dated PosiShot of Silo Pharma, Inc.'s current position, a PosiQR code for its live profile and a ready-made dated mention are available on its For this company page on PositoAI.

Silo Pharma, Inc.

Q: What is Silo Pharma, Inc.'s Positivity rank?

Silo Pharma, Inc. is ranked #2,256 of 6,774 companies globally and #661 of 4,000 in United States on PositoAI, with a Positivity Score of 21,713.

NasdaqCM: SILO · Healthcare

Positivity Index

#2,256 / 6,774

Global

#661 / 4,000

United States

Positivity Score

21,713

Rank→

PosiRed: 1 active red flag (highest severity 6/10) View flag history →

PosiRed · red flag

Stock exchange listing-rule deficiency notice (8-K Item 3.01)

The company reported in a Form 8-K (Item 3.01) filed on 29 Dec 2025 that its stock exchange notified it of not meeting a continued-listing rule. Continued non-compliance can lead to delisting.

More details →

Silo Pharma, Inc. — Overview & Financial Snapshot

Silo Pharma, Inc. (NasdaqCM: SILO) is a Healthcare company, ranked #2,256 of 6,774 companies globally and #661 of 4,000 in United States on PositoAI, with a Positivity Score of 21,713. Its market capitalisation is ₹22.87 Cr ($2.42M), P/E ratio is -0.3 and P/B ratio is 0.50. It currently has 1 active red flag (PosiRed) and no yellow flags (PosiYellow) on record.

For financial statements, ratio trends and score history, Go Deep →